Neurons, a Danish consumer neuroscience company that helps businesses better understand unconscious and conscious responses, secured over €6 million in seed funding.
Fairpoint Capital Vækstfonden and Finance Zealand backed the round.
The investment will be used to attract new talent to secure Neurons’ position as the undisputed global market leader in software prediction services. It will fund the development of unique, state-of-the-art products, the scaling up of the company to 200 employees, and will bring a sizeable increase in annual recurring revenue by 2025.
In a couple of months, Neurons will break new ground by releasing sentiment AI software to enable companies to predict not only what customers will look like but also how they will feel.
Company: Neurons, Inc.
Round: Seed Round
Funding Month: Aug 2022
Lead Investors: Fairpoint Capital Vækstfonden and Finance Zealand
Company Website: https://www.neuronsinc.com/
Software Category: Consumer Neuroscience
About the Company: Founded in 2013 by Majken and Thomas Zoëga Ramsøy, Neurons is the world’s leading consumer neuroscience company. It offers a suite of neuroscience products that comprise Predict, a cloud-based, attention-predicting AI; Explore, a remote neuroscience user testing platform; and Research, a bespoke, full-scale research solution. Neurons have revolutionized the consumer insight space by harnessing the power of neuroscience and AI to provide companies with software that allows them to test customer responses at the touch of a button, instantly supplying more accurate consumer data than deep dive research, for a fraction of the cost. It has worked with Fortune 500 companies, including Google, Facebook, Lowe’s, IKEA, and Tesco to optimize every part of their customer journey, including advertising, retail, user experience, innovation, tech, and beyond. Headquartered in Tåstrup, Neurons opened its doors in Greater Copenhagen in 2021.